Hannover Rück SE Stock Timeline

TickerHNR1.XETRA
Current Price –
Hannover Rück SE – stock chart

Five-year timeline for Hannover Rück SE (HNR1.XETRA): major events, developments and context behind the stock's recent history.

View full stock analysis →

5-year stock timeline

2026 (H1–Q3) — Strong earnings, guidance confirmed; robust capital position

Hannover Re reported very strong first-half results with continued positive quarterly performance in 2026. The company confirmed full-year guidance for Group net income of at least EUR 2.7 bn and proposed an increased dividend following strong 2025 results. CEO Clemens Jungsthöfel emphasised resilience amid challenging market conditions.

Investor perception shifted toward recognition of a high-quality, well-capitalised reinsurance compounder with improving returns on equity and a stated intention to return capital. The messaging conveyed confidence through higher dividends, strong ROE, and capital ratios that signalled financial strength despite market headwinds.

Q1 2026 Group net income reached EUR 710.6 m (compared to EUR 480.5 m in Q1 2025), while H1 2026 Group net income was EUR 1,405.9 m (H1 2025: EUR 1,313.9 m)[2][15]. Annualised return on equity stood at approximately 21% (Q1: 21.2%; H1: 21.5% reported), with shareholders' equity ranging from EUR 13.3 to 13.9 bn as of 31 March and 30 June 2026[2][1]. The Solvency II ratio reached approximately 254% in March and June 2026[2][1].

2026 (May) — AGM approves large dividend increase for 2025 results

The Annual General Meeting approved a dividend of EUR 12.50 per share for the 2025 financial year, representing a 39% increase versus the prior year. The distribution totalled approximately EUR 1.5 bn[3][9].

The board's larger payout and revised dividend policy reinforced a shareholder-friendly stance. Investors increasingly viewed Hannover Re as returning excess capital after record profits, supporting total-return narratives.

2025 (full year) — Record profit, management change completes

Hannover Re closed 2025 with record Group net income of EUR 2,641.5 m and raised guidance for 2026. Clemens Jungsthöfel became Chief Executive Officer effective 1 April 2025, and Dr. Christian Hermelingmeier was appointed CFO effective the same date. The Executive Board underwent realignment as documented in company disclosures[12][5][9].

Market perception moved toward continuity under new leadership with validated execution. The record 2025 result and management renewal reassured investors that the company's strategy—focused on profitable growth, capital strength, and shareholder returns—remained intact.

Shareholders' equity stood at EUR 12.9 bn as of 31 December 2025. The proposed dividend for 2025 of EUR 12.50 per share was subsequently approved at the 2026 AGM[12][5][9].

2024 (full year) — Strong earnings recovery; large-loss frequency high but within budget

Hannover Re reported Group net income of EUR 2,328.7 m in 2024, representing approximately 28% year-over-year growth. The company demonstrated improved combined ratios and managed large-loss expenditure within its disclosed budget for the year despite numerous mid-sized catastrophes. Ratings were affirmed[19][16][17].

Investors perceived a recovery and strengthening of underwriting performance following prior volatility. The company's diversified portfolio and capital strength reinforced a "quality reinsurer" perception. While concerns about catastrophe frequency persisted, they were viewed as manageable within disclosed loss budgets.

Gross written premium reached approximately EUR 29.8 bn. Net large losses for 2024 were approximately EUR 1.63 bn, remaining within the budgeted EUR 1.825 bn. The combined ratio for P&C (net/net, AM Best calculation) improved to approximately 86.6%[19][16][17].

2023 — Stable profitability, improving EPS after prior years of volatility

Hannover Re reported improved operating performance and profitability for 2023, with net income materially higher than 2022. The company continued to emphasise diversification across P&C and life & health segments[19][26].

Investor narrative shifted from concern about earlier losses spanning 2020–2022 toward consistent earnings recovery. Hannover Re was increasingly viewed as executing underwriting discipline and benefiting from higher investment yields.

Group net income for 2023 reached EUR 1,824.8 m[19][26].

2022 — Elevated large losses, above-budget catastrophe costs; pressures on underwriting results

2022 featured elevated large-loss expenditure for the group, with net large losses materially exceeding budget during portions of the year. The P&C claims environment proved challenging, though the company maintained overall capital adequacy and ratings[30][26].

Investor perception was cautious, as underwriting volatility and higher catastrophe costs reminded the market of reinsurance cyclicality. Capital resilience and the diversified portfolio limited downside to the credit profile.

Net large losses for the first nine months of 2022 were reported significantly above budget[30][26].

2021 — Strategic portfolio simplification; focus on pure reinsurance

Hannover Re completed strategic moves to focus on reinsurance, including disposal of a stake in specialty underwriting. The company sold approximately 49.8% of its stake in HDI Global Specialty as part of prior repositioning efforts[21].

Investors viewed these steps as clarifying the company's strategy toward core reinsurance operations, improving transparency and reducing valuation complexity. The company retained strong financial strength ratings[21].

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon